resveratrol has been researched along with nutlin-3a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Butkiewicz, D; Głowala-Kosińska, M; Krześniak, M; Matuszczyk, I; Rusin, M; Zajkowicz, A | 1 |
1 other study(ies) available for resveratrol and nutlin-3a
Article | Year |
---|---|
Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol.
Topics: Anticarcinogenic Agents; Base Sequence; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Primers; Fluorescent Antibody Technique; Gene Knockdown Techniques; Humans; Imidazoles; Molecular Sequence Data; Phosphoprotein Phosphatases; Piperazines; Point Mutation; Protein Phosphatase 2C; Proto-Oncogene Proteins c-mdm2; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Stilbenes; Tumor Suppressor Protein p53 | 2013 |